cardiomyopathy

Bristol Myers Squibb

Pharma

Trial win for BMS sets up Camzyos for pediatric expansion

BMS' cardiomyopathy treatment Camzyos has scored in a trial that could pave the way for it to become available to a younger group of patients.

Kevin Dunleavy Jan 12, 2026 10:25am

green light go go ahead advance yes streetlight

Cytokinetics scores its first FDA nod with Myqorzo approval

Dec 22, 2025 12:05pm

Rocket with heart on blue background

Is Pfizer's recent ATTR sales decline in the US a warning sign?

Dec 2, 2025 8:20am

Silhouette of Businessman Entering Lit Door Passage in Darkness

Fierce Biotech

Cytokinetics doesn't want Big Pharma help to overtake Camzyos

Nov 18, 2025 1:30pm

Stethoscope and red heart with pink background

Cytokinetics joins Bristol Myers in funding heart registry

Nov 17, 2025 12:45pm

Pfizer

Pfizer to discontinue low-dose ATTR drug Vyndaqel in US in 2025

Aug 29, 2025 10:40am